Global Intravenous Immunoglobulins Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Immunoglobulin therapy is the use of a mixture of antibodies (immunoglobulins) to treat a number of health conditions. These conditions include primary immunodeficiency, idiopathic thrombocytopenic purpura, chronic inflammatory demyelinating polyneuropathy, Kawasaki disease, certain cases of HIV/AIDS and measles, Guillain-Barre syndrome, and in certain other infections when a more specific immunoglobulin is not available. Depending on the formulation it can be given by injection into muscle, a vein, or under the skin.
Scope of the Report:
This report focuses on the Intravenous Immunoglobulins in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Intravenous formulations began to be approved in the 1980s, which represented a significant improvement over intramuscular objections, as they allowed for a sufficient amount of immunoglobulin to be injected to reach clinical efficacy, although they still had a fairly high rate of adverse effects.
The worldwide market for Intravenous Immunoglobulins is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Intravenous Immunoglobulins Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Intravenous Immunoglobulins, with sales, revenue, and price of Intravenous Immunoglobulins, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Intravenous Immunoglobulins, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Intravenous Immunoglobulins market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Intravenous Immunoglobulins sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Scope of the Report:
This report focuses on the Intravenous Immunoglobulins in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Intravenous formulations began to be approved in the 1980s, which represented a significant improvement over intramuscular objections, as they allowed for a sufficient amount of immunoglobulin to be injected to reach clinical efficacy, although they still had a fairly high rate of adverse effects.
The worldwide market for Intravenous Immunoglobulins is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- CSL Behring
- Grifols
- Octapharma
- Shire
- ADMA Biologics
- Bayer
- Bharat Serum and Vaccines
- Biotest
- China Biologic Products
- Hualan Biological Engineering
- Kedrion Biopharma
- LFB Group
- Sanquin
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Neurology Intravenous Immunoglobulins
- Hematology Intravenous Immunoglobulins
- Immunology Intravenous Immunoglobulins
- Primary Immunodeficiency
- Idiopathic Thrombocytopenic Purpura
- Chronic Inflammatory Demyelinating Polyneuropathy
- Kawasaki Disease
- Guillain-Barre Syndrome
Chapter 1, to describe Intravenous Immunoglobulins Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Intravenous Immunoglobulins, with sales, revenue, and price of Intravenous Immunoglobulins, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Intravenous Immunoglobulins, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Intravenous Immunoglobulins market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Intravenous Immunoglobulins sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW
1.1 Intravenous Immunoglobulins Introduction
1.2 Market Analysis by Type
1.2.1 Neurology Intravenous Immunoglobulins
1.2.2 Hematology Intravenous Immunoglobulins
1.2.3 Immunology Intravenous Immunoglobulins
1.3 Market Analysis by Applications
1.3.1 Primary Immunodeficiency
1.3.2 Idiopathic Thrombocytopenic Purpura
1.3.3 Chronic Inflammatory Demyelinating Polyneuropathy
1.3.4 Kawasaki Disease
1.3.5 Guillain-Barre Syndrome
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 CSL Behring
2.1.1 Business Overview
2.1.2 Intravenous Immunoglobulins Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 CSL Behring Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Grifols
2.2.1 Business Overview
2.2.2 Intravenous Immunoglobulins Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Grifols Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Octapharma
2.3.1 Business Overview
2.3.2 Intravenous Immunoglobulins Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Octapharma Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Shire
2.4.1 Business Overview
2.4.2 Intravenous Immunoglobulins Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Shire Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 ADMA Biologics
2.5.1 Business Overview
2.5.2 Intravenous Immunoglobulins Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 ADMA Biologics Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bayer
2.6.1 Business Overview
2.6.2 Intravenous Immunoglobulins Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bayer Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bharat Serum and Vaccines
2.7.1 Business Overview
2.7.2 Intravenous Immunoglobulins Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bharat Serum and Vaccines Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Biotest
2.8.1 Business Overview
2.8.2 Intravenous Immunoglobulins Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Biotest Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 China Biologic Products
2.9.1 Business Overview
2.9.2 Intravenous Immunoglobulins Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 China Biologic Products Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Hualan Biological Engineering
2.10.1 Business Overview
2.10.2 Intravenous Immunoglobulins Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Hualan Biological Engineering Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Kedrion Biopharma
2.11.1 Business Overview
2.11.2 Intravenous Immunoglobulins Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Kedrion Biopharma Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 LFB Group
2.12.1 Business Overview
2.12.2 Intravenous Immunoglobulins Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 LFB Group Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Sanquin
2.13.1 Business Overview
2.13.2 Intravenous Immunoglobulins Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Sanquin Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL INTRAVENOUS IMMUNOGLOBULINS SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)
3.1 Global Intravenous Immunoglobulins Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Intravenous Immunoglobulins Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Intravenous Immunoglobulins Manufacturer Market Share in 2017
3.3.2 Top 6 Intravenous Immunoglobulins Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 GLOBAL INTRAVENOUS IMMUNOGLOBULINS MARKET ANALYSIS BY REGIONS
4.1 Global Intravenous Immunoglobulins Sales, Revenue and Market Share by Regions
4.1.1 Global Intravenous Immunoglobulins Sales and Market Share by Regions (2013-2018)
4.1.2 Global Intravenous Immunoglobulins Revenue and Market Share by Regions (2013-2018)
4.2 North America Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
4.3 Europe Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
4.5 South America Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
5 NORTH AMERICA INTRAVENOUS IMMUNOGLOBULINS BY COUNTRIES
5.1 North America Intravenous Immunoglobulins Sales, Revenue and Market Share by Countries
5.1.1 North America Intravenous Immunoglobulins Sales and Market Share by Countries (2013-2018)
5.1.2 North America Intravenous Immunoglobulins Revenue and Market Share by Countries (2013-2018)
5.2 United States Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
5.3 Canada Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
5.4 Mexico Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
6 EUROPE INTRAVENOUS IMMUNOGLOBULINS BY COUNTRIES
6.1 Europe Intravenous Immunoglobulins Sales, Revenue and Market Share by Countries
6.1.1 Europe Intravenous Immunoglobulins Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Intravenous Immunoglobulins Revenue and Market Share by Countries (2013-2018)
6.2 Germany Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
6.3 UK Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
6.4 France Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
6.5 Russia Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
6.6 Italy Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
7 ASIA-PACIFIC INTRAVENOUS IMMUNOGLOBULINS BY COUNTRIES
7.1 Asia-Pacific Intravenous Immunoglobulins Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Intravenous Immunoglobulins Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Intravenous Immunoglobulins Revenue and Market Share by Countries (2013-2018)
7.2 China Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
7.3 Japan Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
7.4 Korea Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
7.5 India Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
8 SOUTH AMERICA INTRAVENOUS IMMUNOGLOBULINS BY COUNTRIES
8.1 South America Intravenous Immunoglobulins Sales, Revenue and Market Share by Countries
8.1.1 South America Intravenous Immunoglobulins Sales and Market Share by Countries (2013-2018)
8.1.2 South America Intravenous Immunoglobulins Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
8.3 Argentina Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
8.4 Colombia Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA INTRAVENOUS IMMUNOGLOBULINS BY COUNTRIES
9.1 Middle East and Africa Intravenous Immunoglobulins Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Intravenous Immunoglobulins Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Intravenous Immunoglobulins Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
9.3 UAE Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
9.4 Egypt Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
9.5 Nigeria Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
9.6 South Africa Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
10 GLOBAL INTRAVENOUS IMMUNOGLOBULINS MARKET SEGMENT BY TYPE
10.1 Global Intravenous Immunoglobulins Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Intravenous Immunoglobulins Sales and Market Share by Type (2013-2018)
10.1.2 Global Intravenous Immunoglobulins Revenue and Market Share by Type (2013-2018)
10.2 Neurology Intravenous Immunoglobulins Sales Growth and Price
10.2.1 Global Neurology Intravenous Immunoglobulins Sales Growth (2013-2018)
10.2.2 Global Neurology Intravenous Immunoglobulins Price (2013-2018)
10.3 Hematology Intravenous Immunoglobulins Sales Growth and Price
10.3.1 Global Hematology Intravenous Immunoglobulins Sales Growth (2013-2018)
10.3.2 Global Hematology Intravenous Immunoglobulins Price (2013-2018)
10.4 Immunology Intravenous Immunoglobulins Sales Growth and Price
10.4.1 Global Immunology Intravenous Immunoglobulins Sales Growth (2013-2018)
10.4.2 Global Immunology Intravenous Immunoglobulins Price (2013-2018)
11 GLOBAL INTRAVENOUS IMMUNOGLOBULINS MARKET SEGMENT BY APPLICATION
11.1 Global Intravenous Immunoglobulins Sales Market Share by Application (2013-2018)
11.2 Primary Immunodeficiency Sales Growth (2013-2018)
11.3 Idiopathic Thrombocytopenic Purpura Sales Growth (2013-2018)
11.4 Chronic Inflammatory Demyelinating Polyneuropathy Sales Growth (2013-2018)
11.5 Kawasaki Disease Sales Growth (2013-2018)
11.6 Guillain-Barre Syndrome Sales Growth (2013-2018)
12 INTRAVENOUS IMMUNOGLOBULINS MARKET FORECAST (2018-2023)
12.1 Global Intravenous Immunoglobulins Sales, Revenue and Growth Rate (2018-2023)
12.2 Intravenous Immunoglobulins Market Forecast by Regions (2018-2023)
12.2.1 North America Intravenous Immunoglobulins Market Forecast (2018-2023)
12.2.2 Europe Intravenous Immunoglobulins Market Forecast (2018-2023)
12.2.3 Asia-Pacific Intravenous Immunoglobulins Market Forecast (2018-2023)
12.2.4 South America Intravenous Immunoglobulins Market Forecast (2018-2023)
12.2.5 Middle East and Africa Intravenous Immunoglobulins Market Forecast (2018-2023)
12.3 Intravenous Immunoglobulins Market Forecast by Type (2018-2023)
12.3.1 Global Intravenous Immunoglobulins Sales Forecast by Type (2018-2023)
12.3.2 Global Intravenous Immunoglobulins Market Share Forecast by Type (2018-2023)
12.4 Intravenous Immunoglobulins Market Forecast by Application (2018-2023)
12.4.1 Global Intravenous Immunoglobulins Sales Forecast by Application (2018-2023)
12.4.2 Global Intravenous Immunoglobulins Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
1.1 Intravenous Immunoglobulins Introduction
1.2 Market Analysis by Type
1.2.1 Neurology Intravenous Immunoglobulins
1.2.2 Hematology Intravenous Immunoglobulins
1.2.3 Immunology Intravenous Immunoglobulins
1.3 Market Analysis by Applications
1.3.1 Primary Immunodeficiency
1.3.2 Idiopathic Thrombocytopenic Purpura
1.3.3 Chronic Inflammatory Demyelinating Polyneuropathy
1.3.4 Kawasaki Disease
1.3.5 Guillain-Barre Syndrome
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 CSL Behring
2.1.1 Business Overview
2.1.2 Intravenous Immunoglobulins Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 CSL Behring Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Grifols
2.2.1 Business Overview
2.2.2 Intravenous Immunoglobulins Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Grifols Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Octapharma
2.3.1 Business Overview
2.3.2 Intravenous Immunoglobulins Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Octapharma Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Shire
2.4.1 Business Overview
2.4.2 Intravenous Immunoglobulins Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Shire Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 ADMA Biologics
2.5.1 Business Overview
2.5.2 Intravenous Immunoglobulins Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 ADMA Biologics Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bayer
2.6.1 Business Overview
2.6.2 Intravenous Immunoglobulins Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bayer Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bharat Serum and Vaccines
2.7.1 Business Overview
2.7.2 Intravenous Immunoglobulins Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bharat Serum and Vaccines Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Biotest
2.8.1 Business Overview
2.8.2 Intravenous Immunoglobulins Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Biotest Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 China Biologic Products
2.9.1 Business Overview
2.9.2 Intravenous Immunoglobulins Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 China Biologic Products Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Hualan Biological Engineering
2.10.1 Business Overview
2.10.2 Intravenous Immunoglobulins Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Hualan Biological Engineering Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Kedrion Biopharma
2.11.1 Business Overview
2.11.2 Intravenous Immunoglobulins Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Kedrion Biopharma Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 LFB Group
2.12.1 Business Overview
2.12.2 Intravenous Immunoglobulins Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 LFB Group Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Sanquin
2.13.1 Business Overview
2.13.2 Intravenous Immunoglobulins Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Sanquin Intravenous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL INTRAVENOUS IMMUNOGLOBULINS SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)
3.1 Global Intravenous Immunoglobulins Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Intravenous Immunoglobulins Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Intravenous Immunoglobulins Manufacturer Market Share in 2017
3.3.2 Top 6 Intravenous Immunoglobulins Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 GLOBAL INTRAVENOUS IMMUNOGLOBULINS MARKET ANALYSIS BY REGIONS
4.1 Global Intravenous Immunoglobulins Sales, Revenue and Market Share by Regions
4.1.1 Global Intravenous Immunoglobulins Sales and Market Share by Regions (2013-2018)
4.1.2 Global Intravenous Immunoglobulins Revenue and Market Share by Regions (2013-2018)
4.2 North America Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
4.3 Europe Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
4.5 South America Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
5 NORTH AMERICA INTRAVENOUS IMMUNOGLOBULINS BY COUNTRIES
5.1 North America Intravenous Immunoglobulins Sales, Revenue and Market Share by Countries
5.1.1 North America Intravenous Immunoglobulins Sales and Market Share by Countries (2013-2018)
5.1.2 North America Intravenous Immunoglobulins Revenue and Market Share by Countries (2013-2018)
5.2 United States Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
5.3 Canada Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
5.4 Mexico Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
6 EUROPE INTRAVENOUS IMMUNOGLOBULINS BY COUNTRIES
6.1 Europe Intravenous Immunoglobulins Sales, Revenue and Market Share by Countries
6.1.1 Europe Intravenous Immunoglobulins Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Intravenous Immunoglobulins Revenue and Market Share by Countries (2013-2018)
6.2 Germany Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
6.3 UK Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
6.4 France Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
6.5 Russia Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
6.6 Italy Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
7 ASIA-PACIFIC INTRAVENOUS IMMUNOGLOBULINS BY COUNTRIES
7.1 Asia-Pacific Intravenous Immunoglobulins Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Intravenous Immunoglobulins Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Intravenous Immunoglobulins Revenue and Market Share by Countries (2013-2018)
7.2 China Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
7.3 Japan Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
7.4 Korea Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
7.5 India Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
8 SOUTH AMERICA INTRAVENOUS IMMUNOGLOBULINS BY COUNTRIES
8.1 South America Intravenous Immunoglobulins Sales, Revenue and Market Share by Countries
8.1.1 South America Intravenous Immunoglobulins Sales and Market Share by Countries (2013-2018)
8.1.2 South America Intravenous Immunoglobulins Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
8.3 Argentina Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
8.4 Colombia Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA INTRAVENOUS IMMUNOGLOBULINS BY COUNTRIES
9.1 Middle East and Africa Intravenous Immunoglobulins Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Intravenous Immunoglobulins Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Intravenous Immunoglobulins Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
9.3 UAE Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
9.4 Egypt Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
9.5 Nigeria Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
9.6 South Africa Intravenous Immunoglobulins Sales and Growth Rate (2013-2018)
10 GLOBAL INTRAVENOUS IMMUNOGLOBULINS MARKET SEGMENT BY TYPE
10.1 Global Intravenous Immunoglobulins Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Intravenous Immunoglobulins Sales and Market Share by Type (2013-2018)
10.1.2 Global Intravenous Immunoglobulins Revenue and Market Share by Type (2013-2018)
10.2 Neurology Intravenous Immunoglobulins Sales Growth and Price
10.2.1 Global Neurology Intravenous Immunoglobulins Sales Growth (2013-2018)
10.2.2 Global Neurology Intravenous Immunoglobulins Price (2013-2018)
10.3 Hematology Intravenous Immunoglobulins Sales Growth and Price
10.3.1 Global Hematology Intravenous Immunoglobulins Sales Growth (2013-2018)
10.3.2 Global Hematology Intravenous Immunoglobulins Price (2013-2018)
10.4 Immunology Intravenous Immunoglobulins Sales Growth and Price
10.4.1 Global Immunology Intravenous Immunoglobulins Sales Growth (2013-2018)
10.4.2 Global Immunology Intravenous Immunoglobulins Price (2013-2018)
11 GLOBAL INTRAVENOUS IMMUNOGLOBULINS MARKET SEGMENT BY APPLICATION
11.1 Global Intravenous Immunoglobulins Sales Market Share by Application (2013-2018)
11.2 Primary Immunodeficiency Sales Growth (2013-2018)
11.3 Idiopathic Thrombocytopenic Purpura Sales Growth (2013-2018)
11.4 Chronic Inflammatory Demyelinating Polyneuropathy Sales Growth (2013-2018)
11.5 Kawasaki Disease Sales Growth (2013-2018)
11.6 Guillain-Barre Syndrome Sales Growth (2013-2018)
12 INTRAVENOUS IMMUNOGLOBULINS MARKET FORECAST (2018-2023)
12.1 Global Intravenous Immunoglobulins Sales, Revenue and Growth Rate (2018-2023)
12.2 Intravenous Immunoglobulins Market Forecast by Regions (2018-2023)
12.2.1 North America Intravenous Immunoglobulins Market Forecast (2018-2023)
12.2.2 Europe Intravenous Immunoglobulins Market Forecast (2018-2023)
12.2.3 Asia-Pacific Intravenous Immunoglobulins Market Forecast (2018-2023)
12.2.4 South America Intravenous Immunoglobulins Market Forecast (2018-2023)
12.2.5 Middle East and Africa Intravenous Immunoglobulins Market Forecast (2018-2023)
12.3 Intravenous Immunoglobulins Market Forecast by Type (2018-2023)
12.3.1 Global Intravenous Immunoglobulins Sales Forecast by Type (2018-2023)
12.3.2 Global Intravenous Immunoglobulins Market Share Forecast by Type (2018-2023)
12.4 Intravenous Immunoglobulins Market Forecast by Application (2018-2023)
12.4.1 Global Intravenous Immunoglobulins Sales Forecast by Application (2018-2023)
12.4.2 Global Intravenous Immunoglobulins Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
LIST OF TABLES AND FIGURES
Figure Intravenous Immunoglobulins Picture
Table Product Specifications of Intravenous Immunoglobulins
Figure Global Sales Market Share of Intravenous Immunoglobulins by Types in 2017
Table Intra
Figure Intravenous Immunoglobulins Picture
Table Product Specifications of Intravenous Immunoglobulins
Figure Global Sales Market Share of Intravenous Immunoglobulins by Types in 2017
Table Intra
